Moreover, the PSMA-targeted [111In/175Lu]-texaphyrin NPs when illuminated with light showed a potent PDT effect and successfully inhibited PSMA-positive PC3 PIP tumour growth in a subcutaneous xenograft model. This evidence concerns the gene FOLH1 and neoplasm.